ट्रायल रडार AI | ||
|---|---|---|
क्लिनिकल ट्रायल NCT07495423 के लिए Sleep Disorder (Disorder), मूड विकार वर्तमान में सक्रिय, भर्ती नहीं है। सभी विवरणों के लिए क्लिनिकल ट्रायल रडार कार्ड दृश्य और AI खोज उपकरण देखें, या यहाँ कुछ भी पूछें। | ||
एक परीक्षण फ़िल्टर मानदंडों से मेल खाता है
कार्ड दृश्य
Exploring the Efficacy of a Breathing Training Intervention in Patients With Emotionally Regulated Sleep Disorders 188
चिकित्सा परीक्षण का विवरण मुख्य रूप से अंग्रेजी में उपलब्ध है। हालाँकि, ट्रायल रडार AI मदद कर सकता है! बस 'अध्ययन समझाएं' पर क्लिक करें और अपनी चुनी हुई भाषा में परीक्षण की जानकारी देखें और चर्चा करें।
क्लिनिकल ट्रायल NCT07495423 एक हस्तक्रियात्मक चिकित्सकीय अध्ययन है जो Sleep Disorder (Disorder), मूड विकार से जुड़ा हुआ है। परीक्षण वर्तमान में सक्रिय, भर्ती नहीं चल रहा है। इसकी शुरुआत 11 जुलाई 2024 को हुई थी, और इसमें कुल 188 प्रतिभागियों के नामांकन की योजना है। Qilu Hospital of Shandong University इस परीक्षण का नेतृत्व कर रहे हैं और इसके 1 जून 2027 तक पूरा होने की उम्मीद है। ClinicalTrials.gov वेबसाइट पर यह जानकारी 27 मार्च 2026 को अंतिम बार अपडेट की गई थी।
संक्षिप्त सारांश
In recent years, the incidence of sleep disorders, especially insomnia, has been rising. Insomnia can directly lead to damage to patients' daytime functions, such as daytime sleepiness, inattention, etc., affecting people's normal work and life. Insomnia is related to dysfunction of multiple systems such as the cardiovascular and cerebrovascular systems, endocrine systems, digestion and breathing, and plays a vital r...और दिखाएँ
आधिकारिक शीर्षक
Exploring the Efficacy of a Breathing Training Intervention in Patients With Emotionally Regulated Sleep Disorders
स्वास्थ्य स्थितियां
Sleep Disorder (Disorder)मूड विकारप्रकाशन
इस नैदानिक परीक्षण के बारे में प्रकाशित वैज्ञानिक लेख और शोध पत्र:अन्य अध्ययन आईडी
- 293688
NCT नंबर
अध्ययन प्रारंभ तिथि (वास्तविक)
2024-07-11
अंतिम अद्यतन प्रकाशित
2026-03-27
अध्ययन की समाप्ति तिथि (अनुमानित)
2027-06-01
नामांकन (अनुमानित)
188
अध्ययन प्रकार
हस्तक्रियात्मक
चरण
निर्दिष्ट नहीं
स्थिति
सक्रिय, भर्ती नहीं
प्रमुख शब्द
Insomnia
Breathing exercises
heart rate variability
mood disorder
autonomic nervous system
Breathing exercises
heart rate variability
mood disorder
autonomic nervous system
प्राथमिक उद्देश्य
उपचार
डिज़ाइन आवंटन
निर्दिष्ट नहीं
हस्तक्षेप मॉडल
एकल समूह
अंधकरण
कोई नहीं (खुला लेबल)
समूह/हस्तक्षेप
| प्रतिभागी समूह/शाखा | हस्तक्षेप/उपचार |
|---|---|
प्रयोगात्मकconventional clinical intervention Health education and publicity for patients and their families, informing them of medication precautions, dietary guidance | respiratory training intervention The study group received a two-week breathing training program in addition to routine clinical care. The program consisted of three exercises rotated daily: pursed-lip breathing involving slow exhalation through pursed lips at a 2:1 exhalation-to-inhalation ratio, practiced for 15 minutes three times daily; balloon blowing requiring patients to slowly inflate five 1000ml balloons within 15 minutes; and breathing trai...और दिखाएँ |
प्राथमिक परिणाम माप
द्वितीयक परिणाम माप
| परिणाम माप | माप विवरण | समय सीमा |
|---|---|---|
Sleep Onset Latency | Time from lights-off to objectively defined sleep onset determined by sleep staging using the SOMNOmedics HST device, reported in minutes. | After 2 weeks, 1 month, 2 months, and 3 months |
Wake After Sleep Onset | Total duration of wakefulness occurring after sleep onset during the night, reported in minutes. | After 2 weeks, 1 month, 2 months, and 3 months |
Sleep Efficiency | Percentage of total sleep time relative to total time in bed during overnight monitoring, reported as a percentage (%). | After 2 weeks, 1 month, 2 months, and 3 months |
Total Sleep Time | Total duration of sleep recorded during overnight monitoring using the SOMNOmedics HST device, reported in minutes. | After 2 weeks, 1 month, 2 months, and 3 months |
| परिणाम माप | माप विवरण | समय सीमा |
|---|---|---|
Low-Frequency Power of Heart Rate Variability | Low-frequency power component of heart rate variability measured using 24-hour ambulatory electrocardiography, reflecting combined sympathetic and parasympathetic activity, reported in milliseconds squared (ms²). | After 2 weeks, 1 month, 2 months, and 3 months |
High-Frequency Power of Heart Rate Variability | High-frequency power component of heart rate variability measured using 24-hour ambulatory electrocardiography, primarily reflecting parasympathetic (vagal) activity, reported in milliseconds squared (ms²). | After 2 weeks, 1 month, 2 months, and 3 months |
Standard Deviation of Normal-to-Normal Intervals | Standard deviation of normal-to-normal (NN) R-R intervals derived from 24-hour ambulatory electrocardiography as a time-domain measure of overall heart rate variability, reported in milliseconds (ms). | After 2 weeks, 1 month, 2 months, and 3 months |
Pittsburgh Sleep Quality Index (PSQI) | Pittsburgh Sleep Quality Index (PSQI) assesses sleep quality, latency, efficiency, disturbances, medication use, and daytime dysfunction with a total score ranging from 0 to 21, where higher scores indicate poorer sleep quality. | after 2 weeks, after 1 month, after 2 months, after 3 months |
The Insomnia Severity Index | The Insomnia Severity Index (ISI) evaluates the severity of insomnia, distress, and impact on daytime functioning, scoring from 0 to 28, with higher scores indicating more severe insomnia. | after 2 weeks, after 1 month, after 2 months, after 3 months |
The Montreal Cognitive Assessment | The Montreal Cognitive Assessment (MoCA) covers attention, executive functions, memory, language, visuospatial abilities, abstraction, calculation, and orientation, with a total score from 0 to 30, lower scores suggesting worse cognitive function. | after 2 weeks, after 1 month, after 2 months, after 3 months |
The Mini-Mental State Examination (MMSE) | The Mini-Mental State Examination (MMSE) assesses orientation, memory, attention, calculation, recall, and language, with a total score from 0 to 30, lower scores indicating worse cognitive function. | after 2 weeks, after 1 month, after 2 months, after 3 months |
The Hamilton Anxiety Scale | The Hamilton Anxiety Scale (HAMA) measures anxiety's somatic and psychological symptoms, scoring from 0 to 56, with higher scores indicating more severe anxiety symptoms. | after 2 weeks, after 1 month, after 2 months, after 3 months |
The Hamilton Depression Rating Scale | The Hamilton Depression Rating Scale (HAMD) evaluates depressive symptoms across mood, cognition, physical, and behavioral aspects, with a total score from 0 to 52, higher scores indicating more severe depressive symptoms. | after 2 weeks, after 1 month, after 2 months, after 3 months |
The Epworth Sleepiness Scale | The Epworth Sleepiness Scale (ESS) assesses daytime sleepiness, scoring from 0 to 24, with higher scores indicating more severe sleepiness. | after 2 weeks, after 1 month, after 2 months, after 3 months |
भागीदारी सहायक
पात्रता मानदंड
अध्ययन के लिए पात्र आयु
वयस्क, वृद्ध वयस्क
अध्ययन के लिए न्यूनतम आयु
18 Years
अध्ययन के लिए पात्र लिंग
सभी
स्वस्थ स्वयंसेवकों को स्वीकार करता है
हाँ
- Meet the diagnostic criteria for insomnia disorder.
- Be between 18 and 80 years of age, inclusive.
- Have questionnaire scores indicating clinical significance:
Pittsburgh Sleep Quality Index (PSQI) score > 5 Insomnia Severity Index (ISI) score > 7 Hamilton Anxiety Scale (HAMA) score > 7 and/or Hamilton Depression Scale (HAMD) score ≥ 7
- Be able to communicate effectively and provide informed consent in the primary language of the study site.
- Provide written informed consent prior to participation
- Insomnia that is secondary to another underlying physical or medical condition.
- A primary diagnosis of another sleep disorder (e.g., sleep apnea, restless legs syndrome) or a primary mood disorder that is considered the main cause of sleep disturbance.
- Chronic sleep disturbances primarily attributable to environmental or lifestyle factors (e.g., shift work, excessive noise, childcare duties).
कोई संपर्क डेटा नहीं।
1 1 देशों में अध्ययन स्थान
Shandong
Qilu Hospital of Shandong University, Jinan, Shandong, 266700, China